These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34749405)

  • 1. Fetal Hemodynamic Response to Anemia in Early Gestation: Using Hemoglobin Bart's Disease as a Study Model.
    Luewan S; Tongprasert F; Srisupundit K; Traisrisilp K; Jatavan P; Tongsong T
    Ultraschall Med; 2023 Apr; 44(2):e83-e90. PubMed ID: 34749405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal hemodynamic changes and mitochondrial dysfunction in myocardium and brain tissues in response to anemia: a lesson from hemoglobin Bart's disease.
    Luewan S; Apaijai N; Chattipakorn N; Chattipakorn SC; Tongsong T
    BMC Pregnancy Childbirth; 2024 Feb; 24(1):141. PubMed ID: 38365664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular Diastolic Function in Normal Fetuses and Fetuses with Hb Bart's Disease Assessed by Color M-Mode Propagation Velocity using Cardio-STIC-M (Spatio-Temporal Image Correlation M-Mode).
    Tongsong T; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K
    Ultraschall Med; 2016 Oct; 37(5):492-496. PubMed ID: 26529356
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal hemoglobin Bart's hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment.
    Jatavan P; Chattipakorn N; Tongsong T
    J Matern Fetal Neonatal Med; 2018 Apr; 31(7):946-957. PubMed ID: 28277912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cardiac findings using speckle tracking in fetuses with hemoglobin Bart's disease.
    Anuwutnavin S; Russameecharoen K; Ruangvutilert P; Viboonchard S; Yaiyiam C; Sklansky M; DeVore GR
    Ultrasound Obstet Gynecol; 2024 May; ():. PubMed ID: 38706423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal Cardiac Cellular Damage Caused by Anemia in Utero in Hb Bart's Disease.
    Jatavan P; Kumfu S; Tongsong T; Chattipakorn N
    Curr Mol Med; 2021; 21(2):165-175. PubMed ID: 32520686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of fetal hemoglobin Bart's for evaluation of fetal α-thalassemia syndromes: application to prenatal characterization of fetal anemia caused by undiagnosed α-hemoglobinopathy.
    Singha K; Yamsri S; Chaibunruang A; Srivorakun H; Sanchaisuriya K; Fucharoen G; Fucharoen S
    Orphanet J Rare Dis; 2022 Feb; 17(1):45. PubMed ID: 35144630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal Cardiac Inflow Characteristics in Response to Fetal Anemia: Based on Fetal Hemoglobin Bart's Disease at Mid-Pregnancy.
    Sirivat K; Luewan S; Srisupundit K; Jatavan P; Tongsong T
    J Ultrasound Med; 2023 May; 42(5):1007-1013. PubMed ID: 36190159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal myocardial performance (Tei) index in fetal hemoglobin Bart's disease.
    Luewan S; Tongprasert F; Srisupundit K; Tongsong T
    Ultraschall Med; 2013 Aug; 34(4):355-8. PubMed ID: 23386484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal Cardiac Remodeling in Response to Anemia: Using Hemoglobin Bart's Disease as a Study Model.
    Tongsong T; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Jatavan P
    Ultraschall Med; 2020 Apr; 41(2):186-191. PubMed ID: 29415313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Performances of Middle Cerebral Artery Peak Systolic Velocity and Cardiothoracic Diameter Ratio in Predicting Fetal Anemia: Using Fetal Hemoglobin Bart's Disease as a Study Model.
    Chankhunaphas W; Tongsong T; Tongprasert F; Srisupundit K; Luewan S; Traisrisilp K; Jatavan P
    Fetal Diagn Ther; 2021; 48(10):738-745. PubMed ID: 34794140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferior vena cava Doppler indices in fetuses with hemoglobin Bart's hydrops fetalis.
    Luewan S; Tongprasert F; Srisupundit K; Tongsong T
    Prenat Diagn; 2014 Jun; 34(6):577-80. PubMed ID: 24609794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of serum non-transferrin-bound iron levels and fetal cardiac function between fetuses affected with hemoglobin Bart's disease and normal fetuses.
    Jatavan P; Sekararithi R; Jaiwongkam T; Kumfu S; Chattipakorn N; Tongsong T
    Front Med (Lausanne); 2022; 9():1015306. PubMed ID: 36660002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal septum primum excursion (SPE) and septum primum excursion index (SPEI) as sonomarkers of fetal anemia: using hemoglobin Bart's fetuses as a study model.
    Sirilert S; Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    Prenat Diagn; 2016 Jul; 36(7):680-5. PubMed ID: 27174768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal anemia causes placental and maternal cellular damage: a lesson from fetal hemoglobin Bart's disease.
    Luewan S; Apaijai N; Chattipakorn N; Chattipakorn S; Tongsong T
    Placenta; 2024 Apr; 149():72-77. PubMed ID: 38531214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of red blood cell hematology among normal, alpha-thalassemia-1 trait, and hemoglobin Bart's fetuses at mid-pregnancy.
    Srisupundit K; Piyamongkol W; Tongsong T
    Am J Hematol; 2008 Dec; 83(12):908-10. PubMed ID: 18932192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
    Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio.
    Thathan N; Traisrisilp K; Luewan S; Srisupundit K; Tongprasert F; Tongsong T
    BMC Pregnancy Childbirth; 2014 Jul; 14():230. PubMed ID: 25028081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of ultrasound algorithm in prenatal diagnosis of hemoglobin Bart's disease among pregnancies at risk.
    Harn-A-Morn P; Wanapirak C; Sirichotiyakul S; Srisupundit K; Tongprasert F; Luewan S; Tongsong T
    Int J Gynaecol Obstet; 2022 Nov; 159(2):451-456. PubMed ID: 35152406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease.
    Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1005-9. PubMed ID: 24107149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.